Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
23,403,724
-
Share change
-
-1,141,707
-
Total reported value
-
$418,963,572
-
Put/Call ratio
-
203%
-
Price per share
-
$17.90
-
Number of holders
-
115
-
Value change
-
-$32,760,264
-
Number of buys
-
53
-
Number of sells
-
63
Institutional Holders of PARATEK PHARMACEUTICALS INC - COM (PRTK) as of Q4 2017
As of 31 Dec 2017,
PARATEK PHARMACEUTICALS INC - COM (PRTK) was held by
115 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,403,724 shares.
The largest 10 holders included
Omega Fund Management, LLC, BAUPOST GROUP LLC/MA, BlackRock Inc., FMR LLC, Alyeska Investment Group, L.P., Abingworth LLP, Vanguard Group Inc, PICTET ASSET MANAGEMENT LTD, Empyrean Capital Partners, LP, and C WorldWide Group Holding A/S.
This page lists
115
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.